Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
β Scribed by Tomizawa, Yoshio; Kohno, Takashi; Fujita, Takeshi; Kiyama, Masaharu; Saito, Ryusei; Noguchi, Masayuki; Matsuno, Yoshihiro; Hirohashi, Setsuo; Yamaguchi, Naohito; Nakajima, Takashi
- Book ID
- 110061837
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 235 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined the p53 status of 108 NSCLCs compared to the expression of MLH1 and MSH2 proteins. p53 overexpression was demonstrated by IHC in 64% of patients examined, whereas p53 mutations were detected in 43%. Twenty-two percent of mutations were located outside of the hot-spot (exons 5-8) area. p5
A prospective randomized trial compared the administration of intrapleural plus intravenous Corynebacterium parvum (C. parvum) versus placebo in patients with resected Stage I and Stage II non-small cell bronchogenic carcinoma. Treatment consisted of 7 mg C. parvum injected into the pleural space an